Series A co-led by Jeito Capital and Sofinnova Partners, with participation from Arkin Bio, Sanofi Ventures, Sixty Degree Capital, Vives Partners and Apollo Health Ventures Sofinnova Partners seed financed and co-founded Bionyra alongside Frédéric Marrache, MD, PhD, CEO of the company Pipeline includes clinical and IND stage mono and multispecific antibodies with half-life extension engineering […]
Read MoreMore Tag